Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000951816 | SCV001098255 | likely benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000951816 | SCV001904401 | benign | not provided | 2021-05-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271120 | SCV002553303 | benign | Hearing loss, X-linked 6 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029827 | SCV004929731 | uncertain significance | not specified | 2024-09-25 | criteria provided, single submitter | clinical testing | The c.1889G>A (p.R630H) alteration is located in exon 23 (coding exon 23) of the COL4A6 gene. This alteration results from a G to A substitution at nucleotide position 1889, causing the arginine (R) at amino acid position 630 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000951816 | SCV005206687 | likely benign | not provided | criteria provided, single submitter | not provided |